InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Roberts Brandi. Officer active across 3 companies, notably TFF Pharmaceuticals, Inc.. Cumulatively, 8 disclosures have been logged. Split: 1 buy · 1 sell. Total volume traded: €5k. Activity tracked since 15 August 2023. The latest transaction was filed on 14 September 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Roberts Brandi is a declarant linked to 7 filings in total. In the sampled recent filings from 2023-08-15 to 2026-08-12, the reported buy volume is EUR 4585 and the reported sell volume is EUR 0. The primary role is not provided, but the listed companies are Definium Therapeutics, Inc., where the role is Chief Financial Officer, TFF Pharmaceuticals, Inc., where the role is Director, and Longboard Pharmaceuticals, Inc., where the role is CFO.